These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 17396395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
    Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, Fortin PR, Ginzler E, Bae SC, Barr S, Edworthy S, Isenberg D, Rahman A, Petri M, Alarcón GS, Aranow C, Dooley MA, Rajan R, Sénécal JL, Zummer M, Manzi S, Ramsey-Goldman R, Clarke AE.
    Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
    [Abstract] [Full Text] [Related]

  • 3. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.
    Chen YJ, Chang YT, Wang CB, Wu CY.
    Am J Med; 2010 Dec; 123(12):1150.e1-6. PubMed ID: 21183006
    [Abstract] [Full Text] [Related]

  • 4. Increased risk of malignancy in patients with systemic lupus erythematosus.
    Ramsey-Goldman R, Mattai SA, Schilling E, Chiu YL, Alo CJ, Howe HL, Manzi S.
    J Investig Med; 1998 Jun; 46(5):217-22. PubMed ID: 9676054
    [Abstract] [Full Text] [Related]

  • 5. Risk of malignancy in women with systemic lupus erythematosus.
    Sweeney DM, Manzi S, Janosky J, Selvaggi KJ, Ferri W, Medsger TA, Ramsey-Goldman R.
    J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469
    [Abstract] [Full Text] [Related]

  • 6. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Isenberg D, Rahman A, Aranow C, Dooley MA, Steinsson K, Nived O, Sturfelt G, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, El-Gabalawy H, McCarthy T, St Pierre Y, Ramsey-Goldman R, Clarke A.
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity.
    Bernatsky S, Boivin JF, Joseph L, St Pierre Y, Moore A, Rajan R, Clarke A.
    J Rheumatol; 2002 Dec; 29(12):2551-4. PubMed ID: 12465150
    [Abstract] [Full Text] [Related]

  • 8. Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center.
    Tarr T, Gyorfy B, Szekanecz E, Bhattoa HP, Zeher M, Szegedi G, Kiss E.
    Ann N Y Acad Sci; 2007 Jun; 1108():76-82. PubMed ID: 17893972
    [Abstract] [Full Text] [Related]

  • 9. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J, Szerafin L, Nagy P.
    Orv Hetil; 2005 Mar 06; 146(10):461-9. PubMed ID: 15835344
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
    Lebrun C, Debouverie M, Vermersch P, Clavelou P, Rumbach L, de Seze J, Wiertlevski S, Defer G, Gout O, Berthier F, Danzon A.
    Mult Scler; 2008 Apr 06; 14(3):399-405. PubMed ID: 18420778
    [Abstract] [Full Text] [Related]

  • 12. Lung cancer in systemic lupus erythematosus.
    Bin J, Bernatsky S, Gordon C, Boivin JF, Ginzler E, Gladman D, Fortin PR, Urowitz M, Manzi S, Isenberg D, Rahman A, Petri M, Nived O, Sturfeldt G, Ramsey-Goldman R, Clarke AE.
    Lung Cancer; 2007 Jun 06; 56(3):303-6. PubMed ID: 17291624
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Model program for screening oral cancers in the Roma population].
    Csépe P, Bánóczy J, Dombi C, Forrai J, Gyenes M, Döbrossy L.
    Magy Onkol; 2007 Jun 06; 51(2):95-101. PubMed ID: 17660865
    [Abstract] [Full Text] [Related]

  • 15. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
    Lin YC, Yen JH, Chang SJ, Lin YC.
    Lupus; 2012 Oct 06; 21(11):1250-6. PubMed ID: 22740427
    [Abstract] [Full Text] [Related]

  • 16. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
    Geier D, Hebert B, Potti A.
    Anticancer Res; 2002 Oct 06; 22(6B):3797-9. PubMed ID: 12552996
    [Abstract] [Full Text] [Related]

  • 17. Malignancies associated with systemic sclerosis.
    Szekanecz É, Szamosi S, Horváth Á, Németh Á, Juhász B, Szántó J, Szücs G, Szekanecz Z.
    Autoimmun Rev; 2012 Oct 06; 11(12):852-5. PubMed ID: 22410174
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical experiences with cyclosporin A in patients with systemic lupus erythematosus].
    Tarr T, Zeher M, Szegedi G, Kiss E.
    Orv Hetil; 2005 Dec 04; 146(49):2485-9. PubMed ID: 16398313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.